WASHINGTON— Today, Republican Study Committee Member Rep. Yvette Herrell introduced legislation to require the Food and Drug Administration to produce a report and recommendations on regulatory barriers to domestic manufacturing of medical products that are critical to public health during public health emergencies.
In the earliest days of the pandemic, China threatened to halt lifesaving supplies of medicine to the United States. This highlighted a glaring need to reshore our supply chains and make sure Americans would have access to lifesaving medicine and medical supplies during public health crises.
The Protecting American Lives Act (PAL) Act of 2022 would help begin that effort of reshoring our medical supply chains.
Rep. Yvette Herrell said: “I am proud to introduce the Protecting American Lives Act, which would require the FDA to identify rules and regulations that make it difficult to produce lifesaving drugs in America, so we can clear them out of the way and bring our pharmaceutical production home from China. We cannot entrust the health of millions of Americans to authoritarian regimes, especially in times of global crisis.”
RSC Chairman Banks said: “China should never be able to put us in a similar situation again. If our nation isn’t secure, then we’re not free. The Republican Study Committee is proud to partner with RSC member Rep. Yvette Herrell on this important bill.”
The PAL Act is supported by Heritage Action for America and the Coalition for a Prosperous America.
More info about this bill can be found here.
The Republican Study Committee (RSC) is the largest caucus in Congress with 159 Members. The RSC was founded in 1973 to bring like-minded conservative House members together to promote a strong, principled legislative agenda. For more information on the Republican Study Committee, visit rsc-banks.house.gov.